6 results
8-K
EX-2.1
ADXS
Ayala Pharmaceuticals, Inc.
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:51am
8-K
EX-2.1
ADXS
Ayala Pharmaceuticals, Inc.
20 Oct 23
Ayala Pharmaceuticals Announces Closing of Merger with Biosight
4:31pm
8-K
EX-2.1
ADXS
Ayala Pharmaceuticals, Inc.
1 Aug 23
Ayala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement
9:00am
8-K
EX-2.2
ADXS
Ayala Pharmaceuticals, Inc.
1 Aug 23
Ayala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement
9:00am
425
EX-2.1
ADXS
Ayala Pharmaceuticals, Inc.
19 Oct 22
Business combination disclosure
4:32pm
8-K
EX-2.1
835tkz
19 Oct 22
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement
4:31pm
- Prev
- 1
- Next